Pennington Biomedical Seeks Participants for Alzheimer’s Study

Scientists believe a buildup of protein in the brain (called “amyloid plaque deposits”) may play a key role in the memory loss related to Alzheimer’s disease.

The EARLY research study at Pennington Biomedical will observe whether decreasing amyloid plaque deposits, through the use of an investigational medication, can help slow memory loss, and prevent the development of Alzheimer’s disease in people who do not show signs of dementia.

To qualify for this research study, participants should be 60 to 85 years of age, have normal thinking abilities, and have a friend or family member that is willing to serve as the participant’s study partner (someone who has at least weekly contact with the participant, and who can answer questions once a year.)

Participation in this research study will last approximately five years.

Those interested in volunteering for this research study should call (225) 763-2973, or e-mail

To view all Pennington Biomedical research studies, visit .